Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

Liquid biopsies can detect biomarkers carrying information on the development and progression of cancer. We demonstrated that a 24 plasma-based microRNA signature classifier (MSC) was capable of increasing the specificity of low dose computed tomography (LDCT) in a lung cancer screening trial. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sestini, Stefano, Boeri, Mattia, Marchiano, Alfonso, Pelosi, Giuseppe, Galeone, Carlotta, Verri, Carla, Suatoni, Paola, Sverzellati, Nicola, La Vecchia, Carlo, Sozzi, Gabriella, Pastorino, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741735/
https://www.ncbi.nlm.nih.gov/pubmed/26451608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741735/
https://www.ncbi.nlm.nih.gov/pubmed/26451608

Ejemplares similares